九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02566 九源基因

交易中 09-03 13:37:15

5.490

+0.090

+1.67%

最高5.500	最低5.495	成交量8,400
今开5.500	昨收5.400	日振幅0.09%
总市值13.18亿	流通市值13.18亿	总股本2.40亿
成交额4.62万	换手率0.00%	流通股本2.40亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":5.49,"timestamp":1788413340123,"preClose":5.4,"halted":0,"volume":8400,"delay":0,"changeRate":0.01666666666666664,"floatShares":240000000,"shares":240000000,"eps":0.6583491620229143,"marketStatus":"交易中","change":0.09,"latestTime":"09-03 13:37:15","open":5.5,"high":5.5,"low":5.495,"amount":46198,"amplitude":0.000926,"askPrice":5.49,"askSize":800,"bidPrice":5.24,"bidSize":3800,"shortable":0,"etf":0,"ttmEps":0.6683678334914798,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1788423000000},"marketStatusCode":2,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":5.4,"dividendRate":0.012083,"openAndCloseTimeList":[[1788399000000,1788408000000],[1788411600000,1788422400000]],"volumeRatio":0.562774,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02566","defaultTab":"news","newsList":[{"id":"1193919165","title":"九源基因（02566）拟于9月18日召开临时股东大会 审议募资用途变更及章程修订","url":"https://stock-news.laohu8.com/highlight/detail?id=1193919165","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193919165?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:13","pubTimestamp":1788167611,"startTime":"0","endTime":"0","summary":"九源基因公告，将于2026年9月18日（星期五）14:30在杭州市钱塘区白杨街道8号大街23号第三会议室召开临时股东大会，股权登记日为同日；H股过户登记将于9月15日至18日暂停。所有股东可亲自或委任代表出席并行使表决权。H股持有人须于9月14日16:30前完成过户手续。会议预计用时不超过半天，交通及食宿费用自理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150090541","title":"九源基因（02566）拟动用最高1亿元延续H股回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1150090541","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150090541?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:45","pubTimestamp":1787139957,"startTime":"0","endTime":"0","summary":"8月19日，九源基因公告称，董事会已决议在现有回购授权有效期内，继续实施H股回购计划，拟使用自有资金回购H股，金额上限为人民币1亿元。根据公告内容，股东于2026年6月15日股东周年大会上已向董事会授出回购授权，可回购数量不超过截至该日已发行H股总数10.0%。公司指出，每次回购的H股价格不得高于回购前连续五个交易日H股平均收市价的5.0%。公司提醒投资者在买卖股份时保持审慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162898705","title":"九源基因（02566）续签多项框架协议　2027—2029年关联交易年度上限披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1162898705","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162898705?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:45","pubTimestamp":1787139925,"startTime":"0","endTime":"0","summary":"8月19日，九源基因公告，董事会已批准与华东医药及中美华东续签五项持续关连交易相关协议及安排，涉及采购、分销、生产服务及收益分成等，详情如下：。拟定年度上限均为5.1百万元。2027年年度上限为40.0百万元。拟定年度上限分别为2027年10.0百万元、2028年12.0百万元及2029年8.0百万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660498440","title":"九源基因(02566.HK)拟回购金额最多为1亿元的H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660498440","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660498440?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:44","pubTimestamp":1787139845,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182187651","title":"九源基因（02566）发布2026年中期业绩：上半年营收6.31亿元 净利同比增长1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182187651","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182187651?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:41","pubTimestamp":1787139686,"startTime":"0","endTime":"0","summary":"2026年8月19日，九源基因公布截至2026年6月30日止六个月未经审核运营数据。期内公司实现收入6.31亿元，同比下降1.2%；归属于母公司股东的净利润为9,126.9万元，同比增长1.2%。公司于2026年5月15日完成1.3630亿股未上市股份转换为H股的全流通。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193612325","title":"杭州九源基因生物制药股份有限公司：批准最高1亿元人民币H股回购计划至授权期满","url":"https://stock-news.laohu8.com/highlight/detail?id=1193612325","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193612325?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:41","pubTimestamp":1787139669,"startTime":"0","endTime":"0","summary":"杭州九源基因生物制药股份有限公司正式通过一项H股回购方案，规模上限设定为1亿元人民币，该计划将持续有效至相关授权期限届满之日。此举标志着公司在资本运作层面迈出重要一步，旨在优化股本结构并提升股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660440154","title":"九源基因(02566)公布中期业绩 母公司股东应占净利润9126.9万元 同比增长1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660440154","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660440154?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:39","pubTimestamp":1787139599,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因 公布2026年中期业绩，收入约6.31亿元，同比减少1.23%;母公司股东应占净利润9126.9万元，同比增长1.21%;每股盈利0.38元。报告期内，凭借公司优质的产品供应能力及成本优势，公司两款已集采产品吉欧停、亿喏佳顺利完成续约;此外，去年已上市产品吉新芬、吉立欣在报告期内销售数量均保持较快的增速。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141202611","title":"九源基因（02566）将于8月19日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1141202611","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141202611?lang=zh_cn&edition=full","pubTime":"2026-08-10 19:56","pubTimestamp":1786362969,"startTime":"0","endTime":"0","summary":"九源基因（02566）8月10日在港交所公告，董事会会议定于2026年8月19日（星期三）举行，拟审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其刊发事宜，同时审议中期股息建议（如有）。\n公告显示，董事会目前由执行董事傅航先生、周伟先生，职工代表董事徐飞虎先生，非执行董事吴诗航先生、Albert Esteve Cruella先生、费俊杰先生、严瑋婷女士，以及独立非执行董事周智慧先生、何美仪女士、周德敏博士、黄文礼博士组成。\n此次董事会的召开，将为市场提供公司2026年上半年经营表现及分红计划（如有）的最新信息。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161469996","title":"九源基因发布7月股份变动月报：合计回购348,200股，股本总数维持245,398,800股","url":"https://stock-news.laohu8.com/highlight/detail?id=1161469996","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161469996?lang=zh_cn&edition=full","pubTime":"2026-08-06 18:02","pubTimestamp":1786010565,"startTime":"0","endTime":"0","summary":"报告期内，公司注册股本为人民币245,398,800元，对应已发行股份总数为245,398,800股，每股面值人民币1元，较上月无变动。根据公告，普通股H股于报告期初的已发行股份数量为240,638,200股，库藏股份数量为4,760,600股，总股本为245,398,800股。7月份，公司未进行新增股份发行，合计回购348,200股并将其全数纳入库藏股份。受此影响，截至2026年7月31日，已发行股份降至240,290,000股，库藏股份增至5,108,800股，整体股本总数仍保持245,398,800股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651548914","title":"九源基因(02566)7月15日斥资25.69万港元回购4.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651548914","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651548914?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:14","pubTimestamp":1784110488,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，于2026年7月15日，该公司斥资25.69万港元回购4.5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140067954","title":"九源基因：7月14日回购2.4万股，耗资约14.35万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1140067954","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140067954?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:35","pubTimestamp":1784028947,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年7月14日发布翌日披露报表，确认在香港联合交易所进行股份回购。根据公告，九源基因于2026年7月14日合计回购2.4万股H股，占该次回购前已发行股份约0.00999%。每股最高回购价为港币6.1元，最低回购价为港币5.9元，合计付出价格约14.35万港元。回购完成后，九源基因已发行股本增至约2.45亿股，已发行股份则变动至240,335,000股。公告显示，本次回购基于2026年6月15日通过的购回授权，授权总数为24,151,640股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因：7月14日回购2.4万股，耗资约14.35万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173564716","title":"九源基因7月13日回购17,800股H股，耗资约10.88万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173564716","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173564716?lang=zh_cn&edition=full","pubTime":"2026-07-13 19:37","pubTimestamp":1783942645,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年7月13日公告，公司于香港联合交易所场内回购H股17,800股，占当日前已发行股本的约0.00741%。回购价格范围介乎每股6.06港元至6.34港元，综合平均回购价为6.112港元，涉资总额约10.88万港元。回购完成后，公司已发行股份总数保持245,398,800股，其中240,359,000股为已发行流通股，5,039,800股为库藏股。根据公告，此次股份回购所依据的购回授权于2026年6月15日获股东大会批准，可回购股份数上限为24,151,640股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因7月13日回购17,800股H股，耗资约10.88万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651116168","title":"九源基因(02566.HK)7月13日斥资10.9万港元回购1.78万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651116168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651116168?lang=zh_cn&edition=full","pubTime":"2026-07-13 19:32","pubTimestamp":1783942355,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165246231","title":"九源基因回购21.14万股股份，涉资约137.40万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165246231","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165246231?lang=zh_cn&edition=full","pubTime":"2026-07-10 19:42","pubTimestamp":1783683722,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年7月10日发布翌日披露报表，公告显示公司于2026年7月10日回购211,400股H股，约占回购前已发行股本的0.08787%。此次回购的最高价为每股6.50港元，最低价为每股6.49港元，涉资总额1,374,044港元。公司透露，其回购授权决议于2026年6月15日获通过，可回购股份总数为24,151,640股。公司在公告中确认，本次回购已经获得董事会正式授权，并遵照所有适用的上市规则、法律及其他监管规定进行。该公告由联席公司秘书黄秀签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因回购21.14万股股份，涉资约137.40万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650182038","title":"九源基因(02566)7月10日斥资137.4万港元回购21.14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650182038","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650182038?lang=zh_cn&edition=full","pubTime":"2026-07-10 19:38","pubTimestamp":1783683500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，于2026年7月10日斥资137.4万港元回购21.14万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122920921","title":"九源基因更新6月股份变动月报表，回购878,200股","url":"https://stock-news.laohu8.com/highlight/detail?id=1122920921","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122920921?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:45","pubTimestamp":1783327553,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年7月6日披露6月股份变动月报表，报告期为2026年6月1日至6月30日。根据公告，截至本月末，公司注册股本总额保持在245,398,800股，面值为每股人民币1元。月初时公司已发行股份为241,516,400股，库存股份为3,882,400股。6月内，公司通过多次购回合计878,200股股份并将其转为库存股份，使本月底库存股份增至4,760,600股，对应流通股份降至240,638,200股。所有回购股份目前均作为库存股份持有，尚未注销。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196390067","title":"九源基因：7月2日回购5万股股份，耗资约29.96万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196390067","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196390067?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:56","pubTimestamp":1782993373,"startTime":"0","endTime":"0","summary":"九源基因于2026年7月2日公告，公司当日在香港联交所场内回购普通股（H股）5万股，占回购前已发行股本约0.02078%。回购价格介于每股5.94港元至6港元，合共耗资约29.96万港元。本次回购后，公司已发行股本变动为240,588,200股，库藏股增至4,810,600股，总股本维持245,398,800股。公司指出，此次回购依据2026年6月15日通过的购回授权展开，该授权允许回购股份总数24,151,640股。本公告由九源基因联席公司秘书黄秀签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因：7月2日回购5万股股份，耗资约29.96万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648504033","title":"九源基因(02566.HK)7月2日斥资29.96万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648504033","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648504033?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:35","pubTimestamp":1782992109,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648040355","title":"九源基因(02566)7月2日斥资29.96万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648040355","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648040355?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:35","pubTimestamp":1782992109,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，于2026年7月2日斥资29.96万港元回购5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647559817","title":"九源基因(02566.HK)6月30日斥资25.2万港元回购4.42万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647559817","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647559817?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:58","pubTimestamp":1782824337,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-gene.com","stockEarnings":[{"period":"1week","weight":0.0286},{"period":"1month","weight":-0.0146},{"period":"3month","weight":-0.0298},{"period":"6month","weight":-0.3339},{"period":"1year","weight":-0.6013},{"period":"ytd","weight":-0.2776}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0023},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.0073},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州九源基因生物医药股份有限公司（原名：杭州九源基因工程股份有限公司）是一家主要从事研发、生产及商业化生物药品和医疗器械的中国公司。该公司专注于骨科、代谢疾病、肿瘤及血液治疗领域。该公司的骨科产品包括骨优导骨修复材料。该公司的肿瘤产品包括吉利芬、吉巨芬、吉欧停、吉芙惟、吉坦苏。该公司的血液产品包括吉派林、亿喏佳。该公司的产品主要用于治疗糖尿病、多发性骨髓瘤、血小板减少症、中性粒细胞减少症等疾病。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"九源基因","nameEN":"JIUYUAN GENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九源基因,02566,九源基因股票,九源基因股票老虎,九源基因股票老虎国际,九源基因行情,九源基因股票行情,九源基因股价,九源基因股市,九源基因股票价格,九源基因股票交易,九源基因股票购买,九源基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}